ASCO: CTC Heterogeneity Predicts Hormone Tx Response in mCRPC
Patients with higher heterogeneity score did not respond well to hormone therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.